99 development-"https:" "https:" "https:" "https:" "https:" "Inria" Postdoctoral positions at Rutgers University
Sort by
Refine Your Search
-
research on characterizing non-coding regulatory elements in humans and understanding how these elements change across different conditions. The project will involve developing new modeling approaches
-
. For additional information please see the Non-Discrimination Statement at the following web address: http://uhr.rutgers.edu/non-discrimination-statement
-
projects to develop, validate, improve, and apply analytical methods for the identification and quantification of metabolites relevant to chronic diseases using advanced mass spectrometry-based techniques
-
Frelinghuysen Road, Piscataway, New Jersey 08854. Email: [email protected]. Lab website: https://sites.rutgers.edu/wei-xing-zong/ Position Status Full Time Posting Number 26FA0287 Posting Open Date 03
-
laboratory techniques, instrumentation, etc., to develop the skills necessary to perform required functions. FLSA Exempt Grade Salary Details Minimum Salary 20,000 Mid Range Salary 90,000 Maximum Salary
-
optogenetics and designer receptors exclusively activated by designer drugs (DREADDs), as appropriate to the project. Develops and applies computational workflows for electrophysiology, imaging, and behavioral
-
Postdoctoral Associate position is available at Rutgers Cancer Institute in Christian Hinrichs’s laboratory to conduct research on tumor immunology with a focus on the discovery and development of T cell therapy
-
sources, and to provide training in cutting‑edge techniques and career development. Among the key duties of this position are the following: Performs independent research involving mammalian cell culture
-
of the Feng lab is to study the development and progression of cancer, including cancer metastasis, cancer metabolic reprogramming and tumor microenvironment. Specific research directions in the lab include: 1
-
(TurboID), phosphoproteomics, and mouse models (including bGHTg acromegaly mice and breast cancer xenografts), we aim to uncover fundamental mechanisms of IGF1R antagonism and develop peptide‑based